Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Bausch + Lomb Corporation Common Shares (NY:BLCO)

16.61 +0.33 (+2.03%)

Official Closing Price Updated: 7:00 PM EDT, Jul 28, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	810,058
Open	16.56
Bid (Size)	15.00 (100)
Ask (Size)	18.37 (100)
Prev. Close	16.28
Today's Range	16.30 - 16.80
52wk Range	13.09 - 18.91
Shares Outstanding	353,800,000
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Bausch + Lomb (BLCO) Reports Earnings Tomorrow: What To Expect

July 27, 2026

Eyecare company Bausch + Lomb (NYSE:BLCO) will be reporting earnings this Wednesday before market hours. Here’s what to expect. Bausch + Lomb beat analysts’ ...

Via StockStory

3 Reasons to Avoid BLCO and 1 Stock to Buy Instead

July 22, 2026

Over the past six months, Bausch + Lomb’s stock price fell to $15.99. Shareholders have lost 7% of their capital, which is disappointing considering the S&P ...

Via StockStory

Performance

YTD	+0.2%	+0.2%
1 Month	-0.1%	-0.1%
3 Month	+5.7%	+5.7%
6 Month	-1.4%	-1.4%
1 Year	+15.0%	+15.0%

More News

Bausch + Lomb Launches EyeGility™ Inserter Preloaded IOL Delivery System in the United States

July 16, 2026

From Bausch + Lomb Corporation

Via Business Wire

Why Bausch + Lomb (BLCO) Stock Is Trading Lower Today

July 10, 2026

Via StockStory

Bausch + Lomb Corp (NYSE:BLCO) Beats Q1 Estimates, Raises Full-Year Guidance ↗

April 29, 2026

Via Chartmill

Bausch + Lomb Announces Phase 2 Results for Glaucoma Neuroprotective Candidate

July 09, 2026

From Bausch + Lomb

Via Business Wire

Bausch + Lomb Introduces Orphia™, an AI-Powered Digital Health Platform Built to Return Physicians to Patient Care

July 09, 2026

From Bausch + Lomb

Via Business Wire

Bausch + Lomb Will Release Second-Quarter 2026 Financial Results on July 29

July 06, 2026

From Bausch + Lomb Corporation

Via Business Wire

July 06, 2026

Via StockStory

New Bausch + Lomb Data Show that Addressing Dry Eye Symptoms is Associated with Improved Quality of Life, Including Lower Anxiety and Increased Self-Confidence

July 01, 2026

From Bausch + Lomb Corporation

Via Business Wire

3 Small-Cap Stocks We Steer Clear Of

June 30, 2026

Via StockStory

1 Stock Under $50 to Own for Decades and 2 We Turn Down

June 25, 2026

Via StockStory

Bausch + Lomb Launches Blink® Triple Care Preservative Free Lubricant Eye Drops in the United States

June 01, 2026

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference

May 21, 2026

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Announces 2026 Annual Meeting of Shareholder Results

May 20, 2026

From Bausch + Lomb Corporation

Via Business Wire

Medical Devices & Supplies - Specialty Stocks Q1 Teardown: Bausch + Lomb (NYSE:BLCO) Vs The Rest

May 19, 2026

Via StockStory

Bausch + Lomb Launches PreserVision AREDS3™ Eye Vitamins in the United States

May 19, 2026

From Bausch + Lomb Corporation

Via Business Wire

3 Profitable Stocks We’re Skeptical Of

May 18, 2026

Via StockStory

Bausch + Lomb Launches Bi-Blade+™ Dual-Port Vitrectomy Cutter in Europe

May 07, 2026

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Announces Second R&D “Teach-in” Webinar

May 06, 2026

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb (BLCO) Q1 2026 Earnings Transcript ↗

April 30, 2026

Via The Motley Fool

Bausch + Lomb to Feature More Than 40 Scientific Studies at the 2026 Association for Research in Vision and Ophthalmology Annual Meeting

April 30, 2026

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb (NYSE:BLCO) Posts Better-Than-Expected Sales In Q1 CY2026

April 29, 2026

Via StockStory

Bausch + Lomb Announces First-Quarter 2026 Results, Raises Guidance Based on Strong Performance and Positive Outlook

April 29, 2026

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb (BLCO) Q1 Earnings Report Preview: What To Look For

April 27, 2026

Via StockStory

Frequently Asked Questions

Is Bausch + Lomb Corporation Common Shares publicly traded?

Yes, Bausch + Lomb Corporation Common Shares is publicly traded.

What exchange does Bausch + Lomb Corporation Common Shares trade on?

Bausch + Lomb Corporation Common Shares trades on the New York Stock Exchange

What is the ticker symbol for Bausch + Lomb Corporation Common Shares?

The ticker symbol for Bausch + Lomb Corporation Common Shares is BLCO on the New York Stock Exchange

What is the current price of Bausch + Lomb Corporation Common Shares?

The current price of Bausch + Lomb Corporation Common Shares is 16.61

When was Bausch + Lomb Corporation Common Shares last traded?

The last trade of Bausch + Lomb Corporation Common Shares was at 07/28/26 07:00 PM ET

What is the market capitalization of Bausch + Lomb Corporation Common Shares?

The market capitalization of Bausch + Lomb Corporation Common Shares is 5.88B

How many shares of Bausch + Lomb Corporation Common Shares are outstanding?

Bausch + Lomb Corporation Common Shares has 6B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.